Wonjong Si (pending final confirmation)

Director, Cell Therapy Platform Process at Bayer

Speaker

I have a decade of experience in stem cell research, spanning both drug discovery and cell therapy. Currently, I specialize in process development for cell therapy, focusing on scalable, automated, and cost-effective manufacturing solutions. With expertise in pluripotent stem cell expansion, bioprocess engineering, and real-time analytics, I am dedicated to advancing the commercialization of regenerative medicine. I am passionate about bridging scientific innovation with industrial application to make cell therapies more accessible.